|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Alcohol-Related Disorders | |||||
| Opioid-Related Disorders | |||||
| Substance-Related Disorders | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Disorders of Environmental Origin | |||||
| Mental Disorders | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| Nitrous oxide | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Sevoflurane | |||||
| 6 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anesthetics | |||||
| Anesthetics, General | |||||
| Anesthetics, Inhalation | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Hematologic Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Platelet Aggregation Inhibitors | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute on Drug Abuse (NIDA) | |||||
| University of Chicago | |||||